News

Liver cancer death rates have increased by around 50% in the last decade and have tripled since records began, according to the latest calculations by Cancer Research UK. New mortality data shows that there were around 5,700 deaths from liver cancer in 2017 in…

Using a non-invasive imaging technique that measures the stiffness of tissues gives crucial new information about cancer architecture and could aid the delivery of treatment to the most challenging tumours, new research shows. Magnetic resonance elastography was able to visualise and measure…

A cancer therapy invented at Rice University has crossed a milestone in clinical trials, a major development in a decades long quest to develop a treatment that destroys tumors without the debilitating side effects of chemotherapy, invasive surgery and radiation. According to the…

A cluster of interacting proteins that are active in both human cancers and Tasmanian devil facial tumours, may give clues to how cancers evade the immune system. This early work in cells could one day guide us towards new drug combinations that…

Researchers from the Environmental Working Group (EWG) in Washington, DC, used a new approach to analyze cumulative cancer risk due to carcinogens in tap water across the U.S. This study is the first to apply a "cumulative cancer risk framework" to the analysis of tap…

Acinetobacter baumannii is a pathogen that causes hospital-acquired infections that are very difficult to treat, because they are resistant to most currently available antibiotics. As one of the World Health Organization's three critical priority pathogens, new antibiotics for Acinetobacter baumannii are urgently needed, and is…

Among women in Chicago, African Americans and Hispanics were exposed to higher levels of ambient toxic heavy metals compared with non-Hispanic whites, and this increased exposure correlated with increased incidence of breast cancer. Garth Rauscher, Ph.D., associate professor of epidemiology at the…

Some colorectal cancer patients with a certain gene mutation benefit from a chemotherapy drug called cetuximab, although the mechanism of how this drug worked was unknown. Scientists have combined computational biology with experimental investigations to discover, for the first time, the mechanism…